BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22102698)

  • 21. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.
    Agalliu I; Kwon EM; Salinas CA; Koopmeiners JS; Ostrander EA; Stanford JL
    Cancer Causes Control; 2010 Feb; 21(2):289-300. PubMed ID: 19902366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
    Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China: Effects of DNA repair genes polymorphisms on genetic damage.
    Zhang GH; Ren JC; Luo M; Cui J; Du Y; Yang D; Cui S; Wang X; Wu W; Cao J; Xia ZL
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Mar; 839():13-20. PubMed ID: 30744808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
    Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.
    Ingles SA; Ross RK; Yu MC; Irvine RA; La Pera G; Haile RW; Coetzee GA
    J Natl Cancer Inst; 1997 Jan; 89(2):166-70. PubMed ID: 8998186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic susceptibility of CYP1A1 gene and risk of pesticide exposure in prostate cancer.
    Abhishek A; Ansari NG; Singh V; Sinha RJ; Mishra P; Mishra A
    Cancer Biomark; 2020; 29(4):429-440. PubMed ID: 31929142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in
    Kaur K; Kaur R
    Biomarkers; 2023 Dec; 28(7):672-679. PubMed ID: 37962435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinesterase homozygous genotype as susceptible biomarker of hypertriglyceridaemia for pesticide-exposed agricultural workers.
    Zhou X; Zhang M; Wang Y; Xia H; Zhu L; Li G; Rong L; Dong H; Chen R; Tang S; Yu M
    Biomarkers; 2021 Jun; 26(4):335-342. PubMed ID: 33617373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.
    Langeberg WJ; Kwon EM; Koopmeiners JS; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):258-64. PubMed ID: 20056646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
    Mandal RK; Gangwar R; Mandhani A; Mittal RD
    DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Variations in Nucleotide Excision Repair Pathway Genes and Risk of Allergic Rhinitis.
    Liu W; Zeng Q; Zeng Y; Tang Y; Luo R
    Mediators Inflamm; 2022; 2022():7815283. PubMed ID: 35693108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editor's Highlight: Base Excision Repair Variants and Pesticide Exposure Increase Parkinson's Disease Risk.
    Sanders LH; Paul KC; Howlett EH; Lawal H; Boppana S; Bronstein JM; Ritz B; Greenamyre JT
    Toxicol Sci; 2017 Jul; 158(1):188-198. PubMed ID: 28460087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A replication study examining association of rs6983267, rs10090154, and rs1447295 common single nucleotide polymorphisms in 8q24 region with prostate cancer in Siberians.
    Oskina NA; Boyarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
    Urol Oncol; 2014 Jan; 32(1):37.e7-12. PubMed ID: 23628314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in XPC and XPD genes modulate DNA damage in pesticide-exposed agricultural workers of Punjab, North-West India.
    Kaur K; Kaur R
    Mol Biol Rep; 2020 Jul; 47(7):5253-5262. PubMed ID: 32562175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variants of DNA repair genes and prostate cancer: a population-based study.
    Ritchey JD; Huang WY; Chokkalingam AP; Gao YT; Deng J; Levine P; Stanczyk FZ; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1703-9. PubMed ID: 16030105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in DNA repair genes, traffic-related polycyclic aromatic hydrocarbon exposure and breast cancer incidence.
    Mordukhovich I; Beyea J; Herring AH; Hatch M; Stellman SD; Teitelbaum SL; Richardson DB; Millikan RC; Engel LS; Shantakumar S; Steck SE; Neugut AI; Rossner P; Santella RM; Gammon MD
    Int J Cancer; 2016 Jul; 139(2):310-21. PubMed ID: 26946191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.